コンテンツへスキップ
Merck

スキップする

E9531

エバスチン

≥98% (HPLC), Histamine H1 receptor antagonist, solid

別名:

1-[4-(1,1-ジメチルエチル)フェニル]-4-[4-(ジフェニルメトキシ)-1-ピペリジニル]-1-ブタノン

ログインで組織・契約価格をご覧ください。

サイズを選択してください

表示を変更する
容量カタログ番号在庫状況単価
10 mg
カートの在庫状況を確認する
¥30,700
50 mg
カートの在庫状況を確認する
¥127,000

この商品について

実験式(ヒル表記法):
C32H39NO2
CAS番号:
分子量:
469.66
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Assay:
≥98% (HPLC)
Form:
solid
Quality level:

¥30,700


カートの在庫状況を確認する
高品質はそのまま、さらにお手頃な価格になりました

バルクの問い合わせ
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします


製品名

エバスチン, ≥98% (HPLC), solid

Quality Level

assay

≥98% (HPLC)

form

solid

color

white

solubility

DMSO: >10 mg/mL, H2O: insoluble

storage temp.

room temp

SMILES string

CC(C)(C)c1ccc(cc1)C(=O)CCCN2CCC(CC2)OC(c3ccccc3)c4ccccc4

InChI

1S/C32H39NO2/c1-32(2,3)28-18-16-25(17-19-28)30(34)15-10-22-33-23-20-29(21-24-33)35-31(26-11-6-4-7-12-26)27-13-8-5-9-14-27/h4-9,11-14,16-19,29,31H,10,15,20-24H2,1-3H3

InChI key

MJJALKDDGIKVBE-UHFFFAOYSA-N

General description

Ebastine is metabolised by cytochrome P450 3A (CYP3A4) to carebastine. It is used to treat allergic rhinitis and chronic idiopathic urticaria.

Application

Ebastine has been used as a cationic amphiphilic drug (CAD) in sensitizing cancerous cells to chemotherapy and revert multidrug resistance.

Biochem/physiol Actions

Ebastine is a non-sedating histamine H1 receptor antagonist, which inhibits allergen-induced bronchospasm in conscious guinea pigs. Unlike other compounds in this category, ebastine does not prolong the QT interval at up to five times the recommended therapeutic dose.
Ebastine is a non-sedating histamine H1 receptor antagonist.

Features and Benefits

This compound is featured on the Histamine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

類似品目との比較

比較内容をすべて表示

相違点を表示

1 of 1

当該品目
SML2794Y0002031329600
Ebastine ≥98% (HPLC), solid

Sigma-Aldrich

E9531

Ebastine

Erastin2 ≥98% (HPLC)

Sigma-Aldrich

SML2794

Erastin2

Ebastine European Pharmacopoeia (EP) Reference Standard

Y0002031

Ebastine

Erastin A cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality.

Sigma-Aldrich

329600

Erastin

form

solid

form

powder

form

-

form

solid

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

-

assay

≥98% (HPLC)

Quality Level

100

Quality Level

100

Quality Level

-

Quality Level

100

storage temp.

room temp

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

−20°C

solubility

DMSO: >10 mg/mL, H2O: insoluble

solubility

DMSO: 2 mg/mL, clear

solubility

-

solubility

DMSO: 50 mg/mL

color

white

color

white to beige

color

-

color

white


Still not finding the right product?

Explore all of our products under エバスチン


保管分類

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



最新バージョンのいずれかを選択してください:

試験成績書(COA)

Lot/Batch Number

適切なバージョンが見つかりませんか。

特定のバージョンが必要な場合は、ロット番号またはバッチ番号で特定の証明書を検索できます。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする


資料

We offers many products related to histamine receptors for your research needs.


Ji-Hong Shon et al.
Journal of clinical pharmacology, 50(2), 195-204 (2009-10-21)
The present study was performed to elucidate the effects of itraconazole and rifampin on the pharmacokinetics and pharmacodynamics of ebastine, a nonsedative H1 receptor antagonist. In a 3-way crossover sequential design with 2-week washouts, 10 healthy participants were pretreated with
Alexander H Schmidt et al.
Journal of pharmaceutical and biomedical analysis, 78-79, 65-74 (2013-03-05)
A stability-indicating ultra high performance liquid chromatographic (UHPLC) method has been developed for purity testing of ebastine and its pharmaceutical formulations. Successful chromatographic separation of the API from impurities was achieved on a Waters Acquity UPLC BEH C18, 50 mm
W Kang et al.
British journal of pharmacology, 163(8), 1733-1739 (2011-03-18)
It is well established that cytochrome P450 2J (CYP2J) enzymes are expressed preferentially in the heart, and that ebastine is a substrate for CYP2J, but it is not known whether ebastine is metabolized in myocardium. Therefore, we investigated its pharmacokinetics



グローバルトレードアイテム番号

カタログ番号GTIN
E9531-50MG04061832072005
E9531-10MG04061832071992

質問

レビュー

評価値なし

アクティブなフィルタ